ANIX · Anixa Biosciences Inc · Documents

$3.18 +0.15 (+4.79%) At close · Nov 6

Market Cap

$110.38M

34.76M

Volume · Nov 6 121.65K Avg daily vol (3M) 277.39K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Net loss $10.93M 10-K filed Jan 12, 2026 Quarterly report FY2026 Q3 Net loss $2.61M 10-Q filed Sep 9, 2026

2026

Sep 11

Investor event

H.C. Wainwright 28th Annual Global Investment Conference AI summary on its way

Sep 9

Quarterly report 10-Q FY2026 Q3, ended Jul 31

Quarterly report for FY2026 Q3 AI summary on its way

Net loss $2.61M Diluted EPS -$0.08

Jun 10

Quarterly report 10-Q FY2026 Q2, ended Apr 30

Quarterly report for FY2026 Q2 AI summary on its way

Net loss $2.52M Diluted EPS -$0.07

Mar 11

Current report 8-K Events of Mar 10

Shareholder vote results, Regulation FD disclosure AI summary on its way

Mar 9

Quarterly report 10-Q FY2026 Q1, ended Jan 31

Quarterly report for FY2026 Q1 AI summary on its way

Net loss $2.57M Diluted EPS -$0.08

Feb 9

Current report 8-K

Regulation FD disclosure AI summary on its way

Jan 28

Proxy statement DEF 14A

Proxy statement AI summary on its way

Jan 12

Annual report 10-K FY2025, ended Oct 31

Annual report for FY2025 AI summary on its way

Net loss $10.93M Diluted EPS -$0.34

2025

Dec 12

Current report 8-K Events of Dec 11

Regulation FD disclosure

Sep 10

Quarterly report 10-Q FY2025 Q3, ended Jul 31

Quarterly report for FY2025 Q3

Net loss $2.26M Diluted EPS -$0.07

Sep 10

Registration statement S-3

Registration statement

May 28

Quarterly report 10-Q FY2025 Q2, ended Apr 30

Quarterly report for FY2025 Q2

Net loss $2.79M Diluted EPS -$0.09

Mar 21

Current report 8-K Events of Mar 20

Shareholder vote results, Regulation FD disclosure

Mar 11

Quarterly report 10-Q FY2025 Q1, ended Jan 31

Quarterly report for FY2025 Q1

Net loss $3.18M Diluted EPS -$0.10

Feb 6

Proxy statement DEF 14A

Proxy statement

Jan 10

Annual report 10-K FY2024, ended Oct 31

Annual report for FY2024

Revenue $210K Net loss $12.55M Diluted EPS -$0.39

2024

Nov 8

Current report 8-K

Regulation FD disclosure

Sep 6

Quarterly report 10-Q FY2024 Q3, ended Jul 31

Quarterly report for FY2024 Q3

Net loss $3.28M Diluted EPS -$0.10

Jun 4

Quarterly report 10-Q FY2024 Q2, ended Apr 30

Quarterly report for FY2024 Q2

Net loss $3.14M Diluted EPS -$0.10

May 8

Current report 8-K Events of May 3

Entered into a material agreement, Regulation FD disclosure

Mar 22

Current report 8-K Events of Mar 21

Shareholder vote results, Regulation FD disclosure

Mar 12

Quarterly report 10-Q FY2024 Q1, ended Jan 31

Quarterly report for FY2024 Q1

Net loss $3.26M Diluted EPS $0.10 ▲ 25.0%

Feb 8

Proxy statement DEF 14A

Proxy statement

Jan 16

Annual report 10-K FY2023, ended Oct 31

Annual report for FY2023

Revenue $210K Net loss $9.81M Diluted EPS $0.32 ▼ 28.9%

2023

Dec 7

Current report 8-K Events of Dec 6

Regulation FD disclosure

Sep 6

Quarterly report 10-Q FY2023 Q3, ended Jul 31

Quarterly report for FY2023 Q3

Net loss $2.51M Diluted EPS -$0.08

Jun 14

Quarterly report 10-Q FY2023 Q2, ended Apr 30

Quarterly report for FY2023 Q2

Revenue $210K Net loss $2.29M

Apr 17

Current report 8-K

Regulation FD disclosure

Mar 17

Quarterly report 10-Q FY2023 Q1, ended Jan 31

Quarterly report for FY2023 Q1

Net loss $2.32M

Mar 10

Current report 8-K Events of Mar 9

Shareholder vote results, Regulation FD disclosure

Jan 27

Proxy statement DEF 14A

Proxy statement

Jan 4

Annual report 10-K FY2022, ended Oct 31

Annual report for FY2022

Net loss $13.6M

2022

Dec 8

Current report 8-K

Regulation FD disclosure

Sep 29

Current report 8-K Events of Sep 28

Regulation FD disclosure

Sep 9

Quarterly report 10-Q FY2022 Q3, ended Jul 31

Quarterly report for FY2022 Q3

Net loss $2.75M

Sep 9

Registration statement S-3

Registration statement

Aug 17

Current report 8-K Events of Aug 15

Other events

Jun 10

Quarterly report 10-Q FY2022 Q2, ended Apr 30

Quarterly report for FY2022 Q2

Net loss $3.54M

Apr 15

Current report 8-K Events of Apr 14

Director or officer change, or executive pay

Mar 11

Current report 8-K Events of Mar 10

Shareholder vote results, Regulation FD disclosure

Mar 11

Quarterly report 10-Q FY2022 Q1, ended Jan 31

Quarterly report for FY2022 Q1

Revenue $513K Net loss $3.83M

Jan 28

Proxy statement DEF 14A

Proxy statement

Jan 4

Annual report 10-K FY2021, ended Oct 31

Annual report for FY2021

Revenue $512.5K Net loss $12.95M

2021

Dec 9

Current report 8-K Events of Dec 7

Shareholder director nominations

Oct 28

Current report 8-K Events of Oct 26

Regulation FD disclosure

Oct 4

Current report 8-K Events of Oct 1

Other events

Sep 1

Quarterly report 10-Q FY2021 Q3, ended Jul 31

Quarterly report for FY2021 Q3

Net loss $4.33M

Jun 16

Current report 8-K

Ended a material agreement

Jun 10

Quarterly report 10-Q FY2021 Q2, ended Apr 30

Quarterly report for FY2021 Q2

Net loss $2.4M

May 27

Current report 8-K Events of May 21

Shareholder vote results, Regulation FD disclosure

Showing 1–50 of 70 documents

Key facts CIK 715446 CUSIP 03528H109 13F (30d) 25 filings 25 filers Visit website Investor relations